Needham Reiterates Buy on Azenta, Maintains $44 Price Target

3/17/2026
Impact: 70
Healthcare

Needham analyst David Saxon has reiterated a Buy rating on Azenta (NASDAQ: AZTA) and has maintained a price target of $44 for the stock. This recommendation suggests confidence in Azenta's performance and potential for growth in the market.

AI summary, not financial advice

Share: